Deutsche Bank AG Buys New Shares in Rapport Therapeutics (NASDAQ:RAPP)
Deutsche Bank AG bought a new stake in Rapport Therapeutics (NASDAQ:RAPP – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,317 shares of the company’s stock, valued at approximately $41,000. A number of other hedge funds and other institutional investors have also […]
Deutsche Bank AG bought a new stake in Rapport Therapeutics (NASDAQ:RAPP – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,317 shares of the company’s stock, valued at approximately $41,000. A number of other hedge funds and other institutional investors have also […]
